0001104659-24-034044.txt : 20240313
0001104659-24-034044.hdr.sgml : 20240313
20240313181739
ACCESSION NUMBER: 0001104659-24-034044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stuglik Brian M
CENTRAL INDEX KEY: 0001716328
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35403
FILM NUMBER: 24747317
MAIL ADDRESS:
STREET 1: C/O VERASTEM, INC.
STREET 2: 117
CITY: NEEDHAM
STATE: MA
ZIP: 02494
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verastem, Inc.
CENTRAL INDEX KEY: 0001526119
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 273269467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: (781) 292-4200
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
4
1
tm248737-7_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-11
0
0001526119
Verastem, Inc.
VSTM
0001716328
Stuglik Brian M
C/O VERASTEM, INC.,
117 KENDRICK ST., SUITE 500
NEEDHAM
MA
02494
1
0
0
0
0
Stock Option (right to buy)
59.04
2024-03-11
4
D
0
4166
D
2028-06-11
Common Stock
2157
0
D
Stock Option (right to buy)
21.72
2024-03-11
4
D
0
7699
D
2029-06-21
Common Stock
2083
0
D
Stock Option (right to buy)
11.44
2024-03-11
4
A
0
11865
A
2034-03-11
Common Stock
11865
11865
D
On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.
The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on October 2, 2017 ending on September 2, 2018.
The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020.
/s/ Daniel Calkins, Attorney in Fact
2024-03-13